Heron Therapeutics
HRTX
HRTX
193 hedge funds and large institutions have $1.1B invested in Heron Therapeutics in 2020 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 81 increasing their positions, 49 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
7.31% less ownership
Funds ownership: 109.99% → 102.69% (-7.3%)
39% less call options, than puts
Call options by funds: $5.87M | Put options by funds: $9.66M
53% less capital invested
Capital invested by funds: $2.33B → $1.1B (-$1.23B)
Holders
193
Holding in Top 10
3
Calls
$5.87M
Puts
$9.66M
Top Buyers
| 1 | +$29.1M | |
| 2 | +$16.4M | |
| 3 | +$10.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$6.52M |
| 5 |
O
OrbiMed
New York
|
+$6.31M |
Top Sellers
| 1 | -$47.7M | |
| 2 | -$40.5M | |
| 3 | -$24.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$24.2M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$20.6M |